Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A fourth subsidiary of OxStem Ltd, an Oxford spin-out co-founded by Professor Steve Davies and Professor Angela Russell has been launched.

 OxStem Cardio, co-founded with Prof. Roger Patient (Professor of Developmental Genetics Weatherall Institute of Molecular Medicine) and Professor Paul Riley (British Heart Foundation Professor of Regenerative Medicine), aims to identify drugs that will restore lost tissue following a heart attack by inducing cardiovascular regeneration, in order to improve cardiac function. This collaborative project will be funded within the University over the next three years following OxStem’s record £16.9M initial fundraise earlier this year.

Similar stories

Jaideep Pandit honoured with RCoA Gold Medal

Congratulations are in order for Professor Jaideep Pandit, Professor of Anaesthesia and consultant anaesthetist, who has received the rarely awarded prestigious Gold Medal of the Royal College of Anaesthetists. Professor Pandit was a student and research fellow at DPAG and is now an Academic Visitor in the department; he is also a Fellow and Tutor in Medicine at St John's College.

Anne C. Ferguson-Smith FRS delivers 2022 Mabel FitzGerald Prize Lecture

The annual lecture is held in honour of pioneering physiologist and high altitude explorer, Mabel Purefoy FitzGerald.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.